Search
Searching with a thematic focus on Intellectual Property Rights, Trade Policy
Showing 351-360 of 420 results
Pages
- Document
Intellectual property rights: ultimate control of agricultural R&D in Asia
Genetic Engineering & Intellectual Property Rights Resource Center, 2001Discusses the pressure on Asian countries to adopt plant variety protection (PVP) systems based on Union for the Protection of New Varieties of Plants UPOV.DocumentImplausible denial: why the drug giants' arguments on patents don't stack up
Oxfam, 2001This paper sets out the counter-arguments to Oxfam’s demand that patent protection should take into account national economic and health circumstances, and explains why Oxfam believes they are unconvincing.Criticisms and recommendations:Whilst patents play an important role in generating incentives for research and development (R&D), the super-profits which patents generate are cDocumentReaching out for small-scale farmers
Biotechnology and Development Monitor, 2000Themed edition of Monitor assessing aspects of biotechnology in development.DocumentBioinformatics and the developing world
Biotechnology and Development Monitor, 1999Bioinformatics is the science of managing and analysing biological information, but the future use of this technology hinges on the availability of bioinformatics knowledge in the public domain.DocumentBiodiversity for sale: dismantling the hype about benefit sharing
GRAIN, 2000This briefing questions whether the world’s primary custodians of biodiversity, local communities and indigenous people, are getting a fair deal. It looks at the implications of the move towards ‘biotrade’ and discusses the validity of intellectual property rights as benefit sharing tools, or as tools to protect indigenous knowledge.DocumentMeanings of sustainable agriculture: some issues for the South
South Centre, 2000This publication explores the various dimensions of sustainable agriculture from the perspective of developing countries.DocumentDrug pricing [in South Africa]
Health Systems Trust, South Africa, 2001Improving access to necessary drugs requires attention to all four component parts of the access equation – ensuring rational selection, providing sustainable financing and efficient systems to distribute and use the drugs and making sure that prices are affordable.However, comparing drugs’ prices across countries and health systems is not always easy.DocumentReview of the TRIPS agreement
Biotechnology and Development Monitor, 1998Themed issue of the Monitor, with chapters submitted by various authors.
